Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

FDA sets LixiLan decision date for Sanofi-Novo diabetes showdown; Eylea could outshine Bayer's sales forecasts, analyst predicts
Fierce Pharma
Mon, 02/22/16 - 06:08 pm
Tags:
FDA, LixiLan, Sanofi, Novo Nordisk, Bayer, Eylea
How Tresiba and Xultophy Will Drive Novo’s Performance
Yahoo/Market Realist
Fri, 02/19/16 - 10:13 am
Tags:
Novo Nordisk, Tresiba, Xultophy, earnings
Why Novo Nordisk Fell after Its 4Q15 Earnings Release
Yahoo/Market Realist
Tue, 02/9/16 - 09:15 am
Tags:
Novo Nordisk, earnings
How Novo’s Diabetes and Obesity Care Segment Performed in 4Q15
Yahoo/Market Realist
Mon, 02/8/16 - 09:29 pm
Tags:
Novo Nordisk, obesity, diabetes, earnings
Insulin wars heat up as Novo's Tresiba bests Lantus in major safety outcomes trial
BioPharma Dive
Thu, 02/4/16 - 09:27 am
Tags:
Novo Nordisk, insulin, diabetes, Tresiba, Lantus, Sanofi
Novo Nordisk outstrips rivals with 8% growth, but lower profits target spooks investors
Fierce Pharma
Wed, 02/3/16 - 05:44 pm
Tags:
Novo Nordisk, earnings
Marketing challenges remain in crowded metabolic market
Medical Marketing and Media
Tue, 01/26/16 - 09:16 pm
Tags:
diabetes, Eli Lilly, Sanofi, Novo Nordisk, obesity
Novo Nordisk rolls out long-awaited Tresiba, aiming for blockbuster market share
Fierce Pharma
Tue, 01/26/16 - 12:36 pm
Tags:
Novo Nordisk, Tresiba, diabetes
Novo Nordisk eyes the future, expands presence in Iran as sanctions lift
BioPharma Dive
Fri, 01/22/16 - 09:30 pm
Tags:
Novo Nordisk, Iran
How Is Novo Nordisk’s Position in the Diabetes Segment?
Yahoo/Market Realist
Mon, 01/18/16 - 08:22 pm
Tags:
Novo Nordisk, diabetes
What to Expect from Novo Nordisk’s 4Q15 Earnings
Yahoo/Market Realist
Mon, 01/18/16 - 08:22 pm
Tags:
Novo Nordisk, earnings
China’s diabetes boom promises $23 billion pot for drug makers
Marketwatch
Fri, 01/15/16 - 02:30 pm
Tags:
China, diabetes, Novo Nordisk, Sanofi, Eli Lilly, Zhejiang Hisun Pharma
Novo Nordisk reinforces its commitment to fight 'urban diabetes' for the New Year
Fierce Pharma Marketing
Tue, 01/5/16 - 11:17 am
Tags:
Novo Nordisk, diabetes
Novo Nordisk: Make-And-Take Strategy For The Obesity Drug Market
Seeking Alpha
Wed, 12/30/15 - 06:55 pm
Tags:
Novo Nordisk, obesity, Saxenda
Sanofi takes an FDA shortcut with its diabetes combo, racing with Novo
Fierce Biotech
Wed, 12/23/15 - 09:34 pm
Tags:
Sanofi, Novo Nordisk, diabetes, FDA, Lantus, lixisenatide
Novo Nordisk eyes stepped-up diabetes care in 'beyond the pill' deal with IBM Watson
Fierce Pharma Marketing
Mon, 12/14/15 - 10:34 pm
Tags:
Novo Nordisk, diabetes
With Paris spotlight on climate change, here's how Big Pharma stacks up
Fierce Pharma
Wed, 12/9/15 - 11:46 am
Tags:
climate change, Sanofi, Biogen, Novo Nordisk, JNJ, Pfizer, Merck, Eli Lilly, Shire, Roche, Bristol-Myers Squibb
Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster
Seeking Alpha
Fri, 11/27/15 - 11:59 am
Tags:
Novo Nordisk, diabetes, semaglutide, GLP-1 agonist
Novo Nordisk's PIONEER Trial Will Establish A New Frontier In Oral Anti-Diabetics
Seeking Alpha
Sat, 11/21/15 - 12:28 pm
Tags:
Novo Nordisk, diabetes, semaglutide
Drug makers beat diabetes lawsuits with an unusual ruling
Pharmalot
Fri, 11/13/15 - 08:49 pm
Tags:
diabetes, FDA, labeling, Merck, Novo Nordisk, Eli Lilly

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.